Clinical researcher Nadine Spring discusses the long-standing lack of diversity in clinical trials and why she's fighting for ...

Carrillo, MD, evaluates the current state of the global availability of clinical trials for patients with renal cell ...

BX211 was safe and well-toleratedBX211 produced sustained and statistically significant1 Percent Area Reduction (PAR) of ulcer size (p = 0.046 at ...

IgniteData is committed to scaling its EHR-to-EDC automation across global research sites, further advancing clinical trial innovation. Insights gained from each deployment will continue to refine and ...

On March 29, 2025, the University of Utah received a revised Notice of Award from the National Center for Advancing ...

Mercy Health’s oncology program is one of eight in the U.S. to take part in a clinical trial to reduce hair loss in breast ...

Experts at City of Hope, a cancer research and treatment center, believe that AI tools will continue to improve precision ...

Among women with suspected ischemia with nonobstructive coronary disease, an intensive medical therapy strategy did not ...

Like lecanemab before it, donanemab’s path to market has been slow and rocky. In the U.S., the antibody received Food and ...

A Phase 2a trial testing foralumab nasal spray in people with nonactive SPMS has dosed the first patients enrolled at Yale MS ...

Frederick L. Locke, MD, discussed cema-cel's safety, efficacy, and potential for treating large B-cell lymphoma in earlier ...

The members of the American Association for Cancer Research (AACR) have elected Keith T. Flaherty, MD, Fellow of the AACR Academy, as the AACR President-Elect for 2025-2026. Flaherty will become ...